Evidence map›Paper›PMID 28627940›Full record

ArticleExpert opinion on drug delivery2017

Delivery of drugs, growth factors, genes and stem cells via intrapericardial, epicardial and intramyocardial routes for sustained local targeted therapy of myocardial disease.

M G Katz, A S Fargnoli, R J Hajjar, C R Bridges

Open access · bronzeAbstract readLetterComment
In one paragraph

Article in Expert opinion on drug delivery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

M G Katza Cardiovascular Research Center , Mount Sinai School of Medicine , New York , NY , USA.
A S Fargnolia Cardiovascular Research Center , Mount Sinai School of Medicine , New York , NY , USA.
R J Hajjara Cardiovascular Research Center , Mount Sinai School of Medicine , New York , NY , USA.
C R Bridgesa Cardiovascular Research Center , Mount Sinai School of Medicine , New York , NY , USA.
Icahn School of Medicine at Mount Sinai · US

Funding

Translational Studies in Heart Failure Gene TherapyR01HL083078 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI BRIDGES, CHARLES R · 2007 to 2018
$9.2M
Anti-AAV Antibodies as an Obstacle to Cardiac AAV Gene TherapyR01HL131404 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WEBER, THOMAS · 2016 to 2019
$3.3M
Treating Ventricle and Valve: New Synergies for Ischemic LV Remodeling with MRR01HL128099 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI AKAR, FADI GABRIEL, LEVINE, ROBERT A · 2016 to 2019
$2.8M
NHLBI NIH HHS R01 HL083078NHLBI NIH HHS R01 HL128099NHLBI NIH HHS R01 HL131404
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CardiomyopathiesPharmaceutical PreparationsHumansIntercellular Signaling Peptides and ProteinsMyocardial InfarctionStem CellsIntercellular Signaling Peptides and ProteinsPharmaceutical Preparations

Identifiers

PMID28627940
PMCPMC5881376
OpenAlexW2683058876

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.